- Home
- SBSW vs QGEN Comparison
SBSW vs QGEN Comparison
Compare SBSW & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SBSW | QGEN |
|---|---|---|
| Founded | 2013 | 1986 |
| Country | South Africa | Netherlands |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8B | 10.2B |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | SBSW | QGEN |
|---|---|---|
| Price | $13.29 | $45.06 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 7 |
| Target Price | $6.90 | ★ $49.74 |
| AVG Volume (30 Days) | ★ 5.2M | 1.2M |
| Earning Date | 08-28-2025 | 11-04-2025 |
| Dividend Yield | N/A | ★ 3.34% |
| EPS Growth | N/A | ★ 331.20 |
| EPS | N/A | ★ 1.84 |
| Revenue | ★ $6,290,132,787.00 | $2,070,781,000.00 |
| Revenue This Year | $14.61 | $7.12 |
| Revenue Next Year | $15.74 | $6.13 |
| P/E Ratio | ★ N/A | $24.59 |
| Revenue Growth | 3.11 | ★ 5.32 |
| 52 Week Low | $3.05 | $37.63 |
| 52 Week High | $14.08 | $51.88 |
Technical Indicators
Market Signals| Indicator | SBSW | QGEN |
|---|---|---|
| Relative Strength Index (RSI) | 64.93 | 42.22 |
| Support Level | $12.10 | $45.55 |
| Resistance Level | $12.81 | $47.48 |
| Average True Range (ATR) | 0.52 | 0.59 |
| MACD | 0.05 | -0.17 |
| Stochastic Oscillator | 68.77 | 11.63 |
Price Performance
Historical ComparisonAbout SBSW D/B/A Sibanye-Stillwater Limited ADS
Sibanye Stillwater Ltd is a South African mining and metals processing group with a diverse portfolio of operations, projects, and investments across five continents. The Group is also one of the foremost recyclers of PGM autocatalysts and has interests in mine tailings retreatment operations. It is a producer of platinum, palladium, and rhodium and is a top-tier gold producer. It also produces and refines iridium and ruthenium, nickel, chrome, copper, and cobalt. Its products are Gold, Nickel, Zinc, Chrome, PGMs, and other.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).